CLINICAL TRIALS PROFILE FOR ALINIA

All Clinical Trials for Alinia

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00130390 ↗	Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease	Terminated	Romark Laboratories L.C.	Phase 2	2005-08-01	The primary objective of this study is to evaluate the efficacy and safety of nitazoxanide compared to a placebo in reducing the signs and symptoms of mild to moderate active Crohn's disease in adults.
NCT00304356 ↗	Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection	Completed	Baylor College of Medicine	Phase 3	2004-01-01	The purpose of this study is for compassionate use of nitazoxanide in the treatment of diarrheal disease due to Clostridium difficile infection when the patient has failed previous treatment with metronidazole or vancomycin.
NCT00304356 ↗	Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection	Completed	Daniel M. Musher MD	Phase 3	2004-01-01	The purpose of this study is for compassionate use of nitazoxanide in the treatment of diarrheal disease due to Clostridium difficile infection when the patient has failed previous treatment with metronidazole or vancomycin.
NCT00304356 ↗	Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection	Completed	VA Medical Center, Houston	Phase 3	2004-01-01	The purpose of this study is for compassionate use of nitazoxanide in the treatment of diarrheal disease due to Clostridium difficile infection when the patient has failed previous treatment with metronidazole or vancomycin.
NCT00384527 ↗	Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease	Terminated	Romark Laboratories L.C.	Phase 3	2006-12-01	The primary objective of the study is to demonstrate non-inferiority of nitazoxanide compared to vancomycin in resolving symptoms of Clostridium difficile-associated disease (CDAD).
NCT00421434 ↗	Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C	Completed	Romark Laboratories L.C.	Phase 2/Phase 3	2006-06-01	The purpose of this study is to evaluate the safety and efficacy of nitazoxanide-peginterferon and nitazoxanide-peginterferon-ribavirin combination regimens compared to the standard of care (peginterferon-ribavirin) in treating chronic hepatitis C genotype 4. The study will also evaluate the effect of the studied treatment regimens on end of treatment virologic response, ALT normalization and safety parameters.

Clinical Trial Conditions for Alinia

Condition Name

Condition Name for Alinia
Intervention	Trials
Chronic Hepatitis C	4
HIV Infection	2
Influenza	1
Clostridium Infections	1

Condition MeSH

Condition MeSH for Alinia
Intervention	Trials
Hepatitis	6
Hepatitis C	6
Hepatitis A	6
Hepatitis, Chronic	4

Clinical Trial Locations for Alinia

Trials by Country

Trials by Country for Alinia
Location	Trials
United States	85
Australia	7
Egypt	4
New Zealand	3
Canada	3

Trials by US State

Trials by US State for Alinia
Location	Trials
New York	7
California	6
Texas	5
Georgia	5
Florida	5

Clinical Trial Progress for Alinia

Clinical Trial Phase

Clinical Trial Phase for Alinia
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	4
Phase 2/Phase 3	4

Clinical Trial Status

Clinical Trial Status for Alinia
Clinical Trial Phase	Trials
Completed	13
Terminated	2
Recruiting	1

Clinical Trial Sponsors for Alinia

Sponsor Name

Sponsor Name for Alinia
Sponsor	Trials
Romark Laboratories L.C.	9
Telethon Kids Institute	2
Baylor College of Medicine	1

Sponsor Type

Sponsor Type for Alinia
Sponsor	Trials
Other	13
Industry	10
U.S. Fed	2